Comprehensive study of neoadjuvant targeted therapy for resectable non-small cell lung cancer

BACKGROUND: Approximately 30–70% percent of patients with non-small cell lung cancer (NSCLC) still relapse after receiving complete resection and even suffer distant metastasis. Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have gradually replaced chemotherapy to become the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Ann Transl Med
Hauptverfasser: Bao, Yi, Gu, Chang, Xie, Huikang, Zhao, Shengnan, Xie, Dong, Chen, Chang, Jiang, Gening, Dai, Chenyang, Zhu, Yuming
Format: Artigo
Sprache:Inglês
Veröffentlicht: AME Publishing Company 2021
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8039639/
https://ncbi.nlm.nih.gov/pubmed/33850890
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-21-1134
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge